UAB Researchers Discover a New Mechanism Involved in Predisposition to Cancer

A team of researchers at the Universitat Autònoma de Barcelona (UAB) has discovered a new mechanism that accelerates the shortening of telomeres (structures that protect the ends of chromosomes) involved in genetic instability and a predisposition to cancer. The research has been published in the journal Human Molecular Genetics.

DNA in higher organisms is organised into individual chromosomes, the ends of which are protected by structures called telomeres. Telomeres are very important in maintaining the cells’ genetic integrity, as they prevent the chromosomes from joining together, protect their ends from degradation and are involved in segregating chromosomes properly during cellular division. They also play a decisive role in two fields that are very important in social and biological terms: cancer and ageing. Telomeres gradually shorten and thus indicate the point at which the cell dies and control the proper proliferation of tissues.

For the first time, a team of researchers at the Universitat Autònoma de Barcelona has observed that telomeres may shorten more quickly due to sudden breakages in the DNA sequence that they consist of. The scientists made this discovery by analysing cells from a genetic syndrome called Fanconi’s anaemia, which is typified by a high genetic instability and chromosomal fragility, and which causes a very high predisposition to contracting cancer in harbourers (a risk of leukaemia 15,000 times higher than in a healthy person). The researchers have observed that the telomeres of affected patients present an accelerated shortening owing to breakages in the telomeric DNA sequence, leading to chromosomes being unprotected and joining together. This mechanism may explain patients’ symtomatology and their tendency to contract cancer. The research thus provides a first experimental link between a predisposition to cancer with the mechanism of sudden shortening of telomeres.

Fanconi’s anaemia came to public notice a little over a year ago (4th October 2000) when the parents of a patient (Molly Nash) genetically selected an embryo so that the newborn baby could become a donor of histocompatible blood for a bone marrow transplant to the infant’s elder sibling.

The interdisciplinary research has been published in Human Molecular Genetics, one of the most prestigious journals on human genetics, and was carried out by the Research Fellow Elsa Callén, under the supervision of Dr. Jordi Surrallés, the Mutagenesis Group “Ramón y Cajal” Researcher in the genetics and Microbiology Department of the UAB, in co-operation with the Spanish National Biotechnology Centre, the Vall d’Hebron Hospital and the Hospital de la Santa Creu i Sant Pau in Barcelona. The study was carried out within the framework of a scientific collaboration agreement between the UAB and the Fanconi Anaemia Research Fund, Inc. in Oregon (USA) and was supported by the Ministry of Health and Consumption Fund for Health Research.

Media Contact

Octavi López Coronado alphagalileo

All latest news from the category: Health and Medicine

This subject area encompasses research and studies in the field of human medicine.

Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.

Back to home

Comments (0)

Write a comment

Newest articles

A world-first antibody-drug delivery system

It sounds like the stuff of science fiction: a man-made crystal that can be attached to antibodies and then supercharge them with potent drugs or imaging agents that can seek…

Revealed: How SARS-CoV-2 evades our immune system

Scientists at Hokkaido University and Texas A&M University have identified a key mechanism used by the SARS-CoV-2 virus to evade host immune systems. Researchers in Japan and the United States…

New approach developed to predict response of immunotherapies in lung cancer

New methodology at the University Hospital of Tübingen harnesses the function of platelets. At Tübingen University Hospital, a preclinical study led by Dr. Clemens Hinterleitner and Prof. Dr. Lars Zender,…

Partners & Sponsors